Form D · Biotechnology
Alavita Pharmaceuticals Inc
Mountain View, CA · CIK 0001340978
Offering snapshot reported Sep 22, 2009 · SEC filing
- Reported sold
- $600K Offering amount: $600K
- Investors reported
- 36 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 10, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 22, 2009 | Initial | $600,000 | No comparison | 36 | SEC filing |
| Nov 24, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 19, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 5, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-81983
Source: Form D, filed Sep 22, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sam Colella | Director |
| Richard Lerner | Director |
| Gordon Ringold | Director, Executive |
| Isaac Stein | Director |
| Alex Zaffaroni | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
325 E. Middlefield Road
Mountain View, CA, 94043
Mountain View, CA, 94043